The Biden Administration's Push to Lower Drug Prices Through March-In Rights.
作者信息
Aaron Daniel G, Anderson J Jonas
机构信息
S.J. Quinney College of Law at The University of Utah, Salt Lake City.
出版信息
JAMA. 2024 Aug 13;332(6):449-450. doi: 10.1001/jama.2024.12327.
PMID:39008321
Abstract
摘要
相似文献
1
The Biden Administration's Push to Lower Drug Prices Through March-In Rights.
JAMA. 2024 Aug 13;332(6):449-450. doi: 10.1001/jama.2024.12327.
2
Senate proposal would reduce drug prices for federal agencies.
Mod Healthc. 1992 Aug 17;22(33):20.
3
Importing Prescription Drugs from Canada - Legal and Practical Problems with the Trump Administration's Proposal.
N Engl J Med. 2020 May 7;382(19):1777-1779. doi: 10.1056/NEJMp2000464.
4
RX for nosebleed prices.
Time. 2001 May 21;157(20):42-3.
5
US Senate launches hearings into soaring prices of off-patent drugs.
BMJ. 2015 Dec 11;351:h6733. doi: 10.1136/bmj.h6733.
6
Pharmaceuticals and medical devices: cost savings.
Issue Brief Health Policy Track Serv. 2012 Jan 3:1-37.
7
Pharmaceuticals and medical devices: cost savings. End-of-year issue brief.
Issue Brief Health Policy Track Serv. 2010 Jan 4:1-18.
8
Pricing, regulation, and competitiveness. Lessons for the US from the Japanese pharmaceutical industry.
Pharmacoeconomics. 1994;6 Suppl 1:67-70. doi: 10.2165/00019053-199400061-00016.
9
A New Way to Contain Unaffordable Medication Costs - Exercising the Government's Existing Rights.
N Engl J Med. 2022 Mar 24;386(12):1104-1106. doi: 10.1056/NEJMp2117102. Epub 2022 Feb 9.
10
Pharmaceutical industry pricing practices: impact of the Bayer settlement.
Health Care Law Mon. 2001 Jul:3-11.
Zotero 插件